LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 12

Suchoptionen

  1. Artikel ; Online: Risk factors for SARS-CoV-2 infection: a test-negative case-control study with additional population controls in Norway.

    Sarjomaa, Marjut / Zhang, Chi / Tveten, Yngvar / Kersten, Hege / Reiso, Harald / Eikeland, Randi / Kongerud, Johny / Berg, Kristine Karlsrud / Thilesen, Carina / Nordbø, Svein Arne / Aaberge, Ingeborg S / Vandenbroucke, Jan / Pearce, Neil / Fell, Anne Kristin Moeller

    BMJ open

    2024  Band 14, Heft 1, Seite(n) e073766

    Abstract: Objectives: This study aims to assess risk factors for SARS-CoV-2 infection by combined design; first comparing positive cases to negative controls as determined by PCR testing and then comparing these two groups to an additional prepandemic population ... ...

    Abstract Objectives: This study aims to assess risk factors for SARS-CoV-2 infection by combined design; first comparing positive cases to negative controls as determined by PCR testing and then comparing these two groups to an additional prepandemic population control group.
    Design and setting: Test-negative design (TND), multicentre case-control study with additional population controls in South-Eastern Norway.
    Participants: Adults who underwent SARS-CoV-2 PCR testing between February and December 2020. PCR-positive cases, PCR-negative controls and additional age-matched population controls.
    Primary outcome measures: The associations between various risk factors based on self- reported questionnaire and SARS-CoV-2 infection comparing PCR-positive cases and PCR-negative controls. Using subgroup analysis, the risk factors for both PCR-positive and PCR-negative participants were compared with a population control group.
    Results: In total, 400 PCR-positive cases, 719 PCR-negative controls and 14 509 population controls were included. Male sex was associated with the risk of SARS-CoV-2 infection only in the TND study (OR 1.9, 95% CI 1.4 to 2.6), but not when PCR-positive cases were compared with population controls (OR 1.2, 95% CI 0.9. to 1.5). Some factors were positively (asthma, wood heating) or negatively (hypertension) associated with SARS-CoV-2 infection when PCR-positive cases were compared with population controls, but lacked convincing association in the TND study. Smoking was negatively associated with the risk of SARS-CoV-2 infection in both analyses (OR 0.5, 95% CI 0.3 to 0.8 and OR 0.6, 95% CI 0.4 to 0.8).
    Conclusions: Male sex was a possible risk factor for SARS-CoV-2 infection only in the TND study, whereas smoking was negatively associated with SARS-CoV-2 infection in both the TND study and when using population controls. Several factors were associated with SARS-CoV-2 infection when PCR-positive cases were compared with population controls, but not in the TND study, highlighting the strength of combining case-control study designs during the pandemic.
    Mesh-Begriff(e) Adult ; Humans ; Male ; COVID-19/diagnosis ; COVID-19/epidemiology ; Population Control ; Case-Control Studies ; SARS-CoV-2 ; Risk Factors ; Norway/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2024-01-08
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2023-073766
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Enlarged lymph nodes plus rash in a man of Mediterranean origin.

    Sarjomaa, Marjut / Majak, Bernard / Ludolph, Thomas / Løberg, Magnus

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2019  Band 139, Heft 6

    Titelübersetzung Forstørrede lymfeknuter og utslett hos en mann fra et middelhavsland.
    Mesh-Begriff(e) Antibiotics, Antineoplastic/therapeutic use ; Exanthema/etiology ; Exanthema/pathology ; Fatal Outcome ; Herpesvirus 8, Human/isolation & purification ; Humans ; Lymph Nodes/pathology ; Male ; Mediterranean Region/ethnology ; Norway ; Sarcoma, Kaposi/diagnosis ; Sarcoma, Kaposi/drug therapy ; Sarcoma, Kaposi/pathology ; Skin Neoplasms/diagnosis ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Stomach Neoplasms/diagnosis ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/pathology
    Chemische Substanzen Antibiotics, Antineoplastic
    Sprache Englisch
    Erscheinungsdatum 2019-03-22
    Erscheinungsland Norway
    Dokumenttyp Case Reports
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.18.0514
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Risk factors for SARS-CoV-2 infection

    Neil Pearce / Svein Arne Nordbø / Chi Zhang / Anne Kristin Moeller Fell / Johny Kongerud / Yngvar Tveten / Jan Vandenbroucke / Randi Eikeland / Harald Reiso / Marjut Sarjomaa / Hege Kersten / Kristine Karlsrud Berg / Carina Thilesen / Ingeborg S Aaberge

    BMJ Open, Vol 14, Iss

    a test-negative case–control study with additional population controls in Norway

    2024  Band 1

    Abstract: Objectives This study aims to assess risk factors for SARS-CoV-2 infection by combined design; first comparing positive cases to negative controls as determined by PCR testing and then comparing these two groups to an additional prepandemic population ... ...

    Abstract Objectives This study aims to assess risk factors for SARS-CoV-2 infection by combined design; first comparing positive cases to negative controls as determined by PCR testing and then comparing these two groups to an additional prepandemic population control group.Design and setting Test-negative design (TND), multicentre case–control study with additional population controls in South-Eastern Norway.Participants Adults who underwent SARS-CoV-2 PCR testing between February and December 2020. PCR-positive cases, PCR-negative controls and additional age-matched population controls.Primary outcome measures The associations between various risk factors based on self- reported questionnaire and SARS-CoV-2 infection comparing PCR-positive cases and PCR-negative controls. Using subgroup analysis, the risk factors for both PCR-positive and PCR-negative participants were compared with a population control group.Results In total, 400 PCR-positive cases, 719 PCR-negative controls and 14 509 population controls were included. Male sex was associated with the risk of SARS-CoV-2 infection only in the TND study (OR 1.9, 95% CI 1.4 to 2.6), but not when PCR-positive cases were compared with population controls (OR 1.2, 95% CI 0.9. to 1.5). Some factors were positively (asthma, wood heating) or negatively (hypertension) associated with SARS-CoV-2 infection when PCR-positive cases were compared with population controls, but lacked convincing association in the TND study. Smoking was negatively associated with the risk of SARS-CoV-2 infection in both analyses (OR 0.5, 95% CI 0.3 to 0.8 and OR 0.6, 95% CI 0.4 to 0.8).Conclusions Male sex was a possible risk factor for SARS-CoV-2 infection only in the TND study, whereas smoking was negatively associated with SARS-CoV-2 infection in both the TND study and when using population controls. Several factors were associated with SARS-CoV-2 infection when PCR-positive cases were compared with population controls, but not in the TND study, highlighting the strength of combining case–control ...
    Schlagwörter Medicine ; R
    Thema/Rubrik (Code) 150
    Sprache Englisch
    Erscheinungsdatum 2024-01-01T00:00:00Z
    Verlag BMJ Publishing Group
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway.

    Sarjomaa, Marjut / Diep, Lien My / Zhang, Chi / Tveten, Yngvar / Reiso, Harald / Thilesen, Carina / Nordbø, Svein Arne / Berg, Kristine Karlsrud / Aaberge, Ingeborg / Pearce, Neil / Kersten, Hege / Vandenbroucke, Jan Paul / Eikeland, Randi / Fell, Anne Kristin Møller

    PloS one

    2022  Band 17, Heft 8, Seite(n) e0264667

    Abstract: Objectives: To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals and the possible predictors of ... ...

    Abstract Objectives: To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals and the possible predictors of antibody persistence.
    Methods: This is the first part of a prospective multi-centre cohort study.
    Participants: The study included SARS-CoV-2 real-time polymerase chain reaction (RT-PCR) positive and negative participants in South-Eastern Norway from February to December 2020. Possible predictors of SARS-CoV-2 total antibody persistence was assessed. The SARS-CoV-2 total antibody levels against spike protein were measured three to five months after PCR in 391 PCR-positive and 703 PCR-negative participants; 212 PCR-positive participants were included in follow-up measurements at 10 to 12 months. The participants completed a questionnaire including information about symptoms, comorbidities, allergies, body mass index (BMI), and hospitalisation.
    Primary outcome: The SARS-CoV-2 total antibody levels against spike protein three to five and 10 to 12 months after PCR positive tests.
    Results: SARS-CoV-2 total antibodies against spike protein were present in 366 (94%) non-vaccinated PCR-positive participants after three to five months, compared with nine (1%) PCR-negative participants. After 10 to 12 months, antibodies were present in 204 (96%) non-vaccinated PCR-positive participants. Of the PCR-positive participants, 369 (94%) were not hospitalised. The mean age of the PCR-positive participants was 48 years (SD 15, range 20-85) and 50% of them were male. BMI ≥ 25 kg/m2 was positively associated with decreased antibody levels (OR 2.34, 95% CI 1.06 to 5.42). Participants with higher age and self-reported initial fever with chills or sweating were less likely to have decreased antibody levels (age: OR 0.97, 95% CI 0.94 to 0.99; fever: OR 0.33, 95% CI 0.13 to 0.75).
    Conclusion: Our results indicate that the level of SARS-CoV-2 total antibodies against spike protein persists for the vast majority of non-vaccinated PCR-positive persons at least 10 to 12 months after mild COVID-19.
    Mesh-Begriff(e) Adult ; Aged ; Aged, 80 and over ; Antibodies, Viral ; COVID-19 ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Norway ; Prospective Studies ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Young Adult
    Chemische Substanzen Antibodies, Viral ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Sprache Englisch
    Erscheinungsdatum 2022-08-10
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0264667
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Risk factors for SARS-CoV-2 infection: A test-negative case-control study with additional population controls

    Sarjomaa, Marjut / Zhang, Chi / Tveten, Yngvar / Kersten, Hege / Reiso, Harald / Eikeland, Randi / Kongerud, Johny / Berg, Kristine Karlsrud / Thilesen, Carina / Nordbo, Svein Arne / Aaberge, Ingeborg / Vandenbroucke, Jan / Pearce, Neil / Fell, Anne Kristin

    medRxiv

    Abstract: ABSTRACT Objectives: To assess risk factors for SARS-CoV-2 infection by first comparing positive cases with negative controls as determined by polymerase chain reaction (PCR) testing and then comparing these two groups with an additional population ... ...

    Abstract ABSTRACT Objectives: To assess risk factors for SARS-CoV-2 infection by first comparing positive cases with negative controls as determined by polymerase chain reaction (PCR) testing and then comparing these two groups with an additional population control group. Design and setting: Test-negative design (TND), multicentre case-control study with additional population controls in South Eastern Norway. Participants: Adults who underwent SARS-CoV-2 PCR testing between February and December 2020. PCR-positive cases, PCR-negative controls, and additional age-matched population controls. Primary outcome measures: The associations between various risk factors based on self- reported questionnaire and SARS-CoV-2 infection comparing PCR positive cases and PCR- negative controls. Using subgroup analysis, the risk factors were then compared with a population control group. Univariate and multivariate regression analyses were performed. Results: In total, 400 SARS-CoV-2 PCR-positive cases, 719 PCR-negative controls, and 14,509 population controls were included. Male sex was associated with the risk of SARS- CoV-2 infection when PCR-positive cases were compared with PCR-negative controls (OR 1.9, 95% CI 1.4 to 2.6). Age, education level, comorbidities (asthma, diabetes, hypertension), an exercise were not associated with the risk of SARS-CoV-2 infection when PCR-positive cases were compared with PCR-negative controls. In the subgroup analysis comparing PCR- positive cases with age-matched population controls, asthma was associated with the risk of SARS-CoV-2 infection (OR 1.6, 95% CI 1.1 to 2.1). Daily or occasional smoking was negatively associated with the risk of SARS-CoV-2 infection in both analyses (OR 0.5, 95% CI 0.3 to 0.8 and OR 0.55, 95% CI 0.35, to 0.82, respectively). Conclusions: Male sex was a possible risk factor, whereas smoking was negatively associated with the risk of SARS-CoV-2 infection, when comparing PCR-positive cases and PCR- negative controls. Asthma was associated with the risk of SARS-CoV-2 infection when PCR- positive cases were compared with population controls.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2023-03-19
    Verlag Cold Spring Harbor Laboratory Press
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2023.03.15.23287300
    Datenquelle COVID19

    Kategorien

  6. Artikel ; Online: SARS-CoV-2 antibody persistence after five and twelve months

    Marjut Sarjomaa / Lien My Diep / Chi Zhang / Yngvar Tveten / Harald Reiso / Carina Thilesen / Svein Arne Nordbø / Kristine Karlsrud Berg / Ingeborg Aaberge / Neil Pearce / Hege Kersten / Jan Paul Vandenbroucke / Randi Eikeland / Anne Kristin Møller Fell

    PLoS ONE, Vol 17, Iss 8, p e

    A cohort study from South-Eastern Norway.

    2022  Band 0264667

    Abstract: Objectives To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals and the possible predictors of ... ...

    Abstract Objectives To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals and the possible predictors of antibody persistence. Methods This is the first part of a prospective multi-centre cohort study. Participants The study included SARS-CoV-2 real-time polymerase chain reaction (RT-PCR) positive and negative participants in South-Eastern Norway from February to December 2020. Possible predictors of SARS-CoV-2 total antibody persistence was assessed. The SARS-CoV-2 total antibody levels against spike protein were measured three to five months after PCR in 391 PCR-positive and 703 PCR-negative participants; 212 PCR-positive participants were included in follow-up measurements at 10 to 12 months. The participants completed a questionnaire including information about symptoms, comorbidities, allergies, body mass index (BMI), and hospitalisation. Primary outcome The SARS-CoV-2 total antibody levels against spike protein three to five and 10 to 12 months after PCR positive tests. Results SARS-CoV-2 total antibodies against spike protein were present in 366 (94%) non-vaccinated PCR-positive participants after three to five months, compared with nine (1%) PCR-negative participants. After 10 to 12 months, antibodies were present in 204 (96%) non-vaccinated PCR-positive participants. Of the PCR-positive participants, 369 (94%) were not hospitalised. The mean age of the PCR-positive participants was 48 years (SD 15, range 20-85) and 50% of them were male. BMI ≥ 25 kg/m2 was positively associated with decreased antibody levels (OR 2.34, 95% CI 1.06 to 5.42). Participants with higher age and self-reported initial fever with chills or sweating were less likely to have decreased antibody levels (age: OR 0.97, 95% CI 0.94 to 0.99; fever: OR 0.33, 95% CI 0.13 to 0.75). Conclusion Our results indicate that the level of SARS-CoV-2 total antibodies against spike protein persists for the ...
    Schlagwörter Medicine ; R ; Science ; Q
    Sprache Englisch
    Erscheinungsdatum 2022-01-01T00:00:00Z
    Verlag Public Library of Science (PLoS)
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway

    Sarjomaa, Marjut / Diep, Lien My / Zhang, Chi / Tveten, Yngvar / Reiso, Harald / Thilesen, Carina / Nordbø, Svein Arne / Berg, Kristine Karlsrud / Aaberge, Ingeborg / Pearce, Neil / Kersten, Hege / Vandenbroucke, Jan Paul / Eikeland, Randi / Fell, Anne Kristin Møller

    medRxiv

    Abstract: Objectives: To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals and the possible predictors of ... ...

    Abstract Objectives: To assess total antibody levels against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS CoV-2) spike protein up to 12 months after Coronavirus Disease (COVID-19) infection in non-vaccinated individuals and the possible predictors of antibody persistence. Methods: This is a prospective multi-centre longitudinal cohort study. Participants The study included SARS-CoV-2 real-time polymerase chain reaction (RT-PCR) positive and negative participants in South-Eastern Norway from February to December 2020. Possible predictors of SARS-CoV-2 total antibody persistence was assessed. The SARS-CoV-2 total antibody levels against spike protein were measured three to five months after PCR in 391 PCR-positive and 703 PCR-negative participants; 212 PCR-positive participants were included in follow-up measurements at 10 to 12 months. The participants completed a questionnaire including information about symptoms, comorbidities, allergies, body mass index (BMI), and hospitalisation. Primary outcome The SARS-CoV-2 total antibody levels against spike protein three to five and 10 to 12 months after PCR positive tests. Results: SARS-CoV-2 total antibodies against spike protein were present in 366 (94%) non-vaccinated PCR-positive participants after three to five months, compared with nine (1%) PCR-negative participants. After 10 to 12 months, antibodies were present in 204 (96%) non-vaccinated PCR-positive participants. Of the PCR-positive participants, 369 (94%) were not hospitalised. The mean age of the PCR-positive participants was 48 years (SD 15, range 20-85) and 50% of them were male. BMI ≥ 25 kg/m 2 was positively associated with decreased antibody levels (OR 2.34, 95% CI 1.06 to 5.42). Participants with higher age and self-reported initial fever with chills or sweating were less likely to have decreased antibody levels (age: OR 0.97, 95% CI 0.94 to 0.99; fever: OR 0.33, 95% CI 0.13 to 0.75).   Conclusion Our results indicate that the level of SARS-CoV-2 total antibodies against spike protein persists for the vast majority of non-vaccinated PCR-positive persons at least 10 to 12 months after mild COVID-19.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2022-02-21
    Verlag Cold Spring Harbor Laboratory Press
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2022.02.16.22271075
    Datenquelle COVID19

    Kategorien

  8. Artikel ; Online: Fra tonsillitt til koksitt.

    Sarjomaa, Marjut / Liyanarachi, Kristin Vardheim / Brekke, Hanne

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2009  Band 129, Heft 17, Seite(n) 1754–1755

    Abstract: We present a 19-year-old woman with a throat infection, increased temperature, a positive mononucleosis monospot test and clinical signs of a lower respiratory tract infection. The diagnosis was thought to be mononucleosis complicated by bacterial ... ...

    Titelübersetzung From tonsillitis to coxitis.
    Abstract We present a 19-year-old woman with a throat infection, increased temperature, a positive mononucleosis monospot test and clinical signs of a lower respiratory tract infection. The diagnosis was thought to be mononucleosis complicated by bacterial pneumonia, but she was later found to have Fusobacterium necrophorum in blood cultures. She subsequently developed metastatic abscesses in her lungs and hip joint and was diagnosed with Lemierre's Syndrome. This case report highlights the importance of close links between clinicians and microbiologists in order to prevent morbidity and mortality in patients with an infectious disease.
    Mesh-Begriff(e) Diagnosis, Differential ; Female ; Fusobacterium Infections/diagnosis ; Fusobacterium necrophorum/isolation & purification ; Humans ; Lung Abscess/diagnostic imaging ; Lung Abscess/etiology ; Lung Abscess/microbiology ; Osteoarthritis, Hip/etiology ; Osteoarthritis, Hip/microbiology ; Osteoarthritis, Hip/pathology ; Radiography ; Syndrome ; Tonsillitis/complications ; Tonsillitis/diagnosis ; Tonsillitis/microbiology ; Young Adult
    Sprache Norwegisch
    Erscheinungsdatum 2009-09-10
    Erscheinungsland Norway
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.08.0218
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Hvordan stoppe multiresistente bakterier?

    Tveten, Yngvar / Sarjomaa, Marjut Anneli / Skaare, Dagfinn / Grude, Nils / Samuelsen, Ørjan

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2011  Band 131, Heft 7, Seite(n) 698–700

    Titelübersetzung How to stop multiresistant bacteria?.
    Mesh-Begriff(e) Communicable Disease Control ; Drug Resistance, Multiple, Bacterial/genetics ; Gram-Negative Bacterial Infections/drug therapy ; Gram-Negative Bacterial Infections/prevention & control ; Humans ; Infection Control ; Norway ; Practice Guidelines as Topic ; beta-Lactamases/genetics
    Chemische Substanzen beta-Lactamases (EC 3.5.2.6)
    Sprache Norwegisch
    Erscheinungsdatum 2011-04-08
    Erscheinungsland Norway
    Dokumenttyp Journal Article
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    DOI 10.4045/tidsskr.10.0369
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Hjerneslag--en studie av klinisk håndtering og forløp.

    Hysing, Jan / Sarjomaa, Marjut / Skog, Karina / Lydersen, Stian

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

    2007  Band 127, Heft 10, Seite(n) 1374–1378

    Abstract: Background: Knowledge on how to treat stroke effectively is increasing, but is not always implemented into clinical practice. The aim of this study was to establish the treatment offered, clinical status at discharge and long-term results for stroke ... ...

    Titelübersetzung Stroke--a study of clinical management and prognosis.
    Abstract Background: Knowledge on how to treat stroke effectively is increasing, but is not always implemented into clinical practice. The aim of this study was to establish the treatment offered, clinical status at discharge and long-term results for stroke patients admitted to a Norwegian local hospital.
    Material and methods: 421 patients were treated for stroke at Baerum hospital during the years 1994-1995. Patient history, medication, radiological findings and clinical findings at admission and discharge were recorded in a local register. Data on survival and re-hospitalisation for recurrent stroke were recorded for a period 7 to 9 years after discharge, i.e. until January 2003.
    Results: Hospital mortality was 17%. 49% were discharged directly to their homes. No antihypertensive treatment was given to 106 (51.6%) of the 206 patients who had hypertension upon discharge. 273 (90%) of the 303 patients discharged after cerebral infarction, were receiving antithrombotic treatment with warfarin or acetylic salicylic acid upon discharge. The most important prognostic factor for survival and functional ability was the patient's age at the time of stroke and next, the stroke's anatomical localization and extent.
    Interpretation: Registers for follow-up of stroke patients provide valuable information on clinical practice and can form a basis for improved treatment of stroke in the future.
    Mesh-Begriff(e) Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Patient Discharge ; Prognosis ; Recurrence ; Registries ; Risk Factors ; Stroke/drug therapy ; Stroke/mortality ; Stroke Rehabilitation
    Sprache Norwegisch
    Erscheinungsdatum 2007-05-17
    Erscheinungsland Norway
    Dokumenttyp Journal Article
    ZDB-ID 603504-8
    ISSN 0807-7096 ; 0029-2001
    ISSN (online) 0807-7096
    ISSN 0029-2001
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang